CD2 regulates the positive selection and function of antigen-specific CD4-CD8+ T cells

Blood

Volumn 89, Issue 4, 1997, Pages 1308-1318

  Teh, Soo Jeet ^b   Killeen, Nigel ^b   Tarakhovsky, Alexander ^b   Littman, Dan R ^b   Teh, Hung Sia ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; GENE EXPRESSION; HELPER CELL; IMMUNE RESPONSE; IMMUNOPRECIPITATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL; THYMUS; TRANSGENIC ANIMAL;

EID: 0031059288     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.4.1308     Document Type: Article

References (62)

1. Moingeon P, Chang H-C, Sayre PH, Clayton LK, Alcover A, Gardner P, Rheinherz EL: The structural biology of CD2. Immunol Rev 111:111, 1989
2. Sewell WA, Brown MH, Owen MJ, Fink PJ, Kozak CA, Crumpton MJ: The murine homologue of the T lymphocyte CD2 antigen: Molecular cloning, chromosome assignment and cell surface expression. Eur J Immunol 17:1015, 1987
3. Spruyt LL, Glennie MJ, Beyers AD, Williams AF: Signal transduction by the CD2 antigen in T cells and natural killer cells: Requirement for expression of a functional T cell receptor or binding of antibody Fc to the Fc receptor, Fc gamma RIIIA (CD16). J Exp Med 174:1407, 1991
4. Law DA, Spruyt LL, Paterson DJ, Williams AF: Subsets of thymopoietic rat thymocytes defined by expression of the CD2 antigen and the MRC OX-22 determinant of the leuckocyte-common antigen CD45. Eur J Immunol 19:2289, 1989
5. Yagita H, Asakawa J, Tansyo S, Nakamura T, Habu S, Okumura K: Expression and function of CD2 during murine thymocyte ontogeny. Eur J Immunol 19:2211, 1989
6. Dustin ML, Sanders ME, Shaw S, Springer TA: Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion. J Exp Med 165:677, 1987
7. Kato K, Koyanagi M, Okada H, Takanashi T, Wong YW, Williams AF: CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med 176:1241, 1992
8. Hahn WC, Menu E, Bothwell AL, Sims PJ, Bierer BE: Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 256:1805, 1992
9. Arulanandam AR, Moingeon P, Concino MF, Recny MA, Kato K, Yagita H, Koyasu S, Reinherz EL: A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: Divergence of CD2 ligands during the evolution of humans and mice. J Exp Med 177:1439, 1993
10. van der Merwe PA, Barclay AN, Mason DW, Davies EA, Morgan BP, Tone M, Krishnam AK, Ianelli C, Davis SJ: Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 33:10149, 1994
11. Wong YW, Williams AF, Kingsmore SF, Seldin MF: Structure, expression, and genetic linkage of the mouse BCM1 (OX45 or Blast-1) antigen. Evidence for genetic duplication giving rise to the BCM1 region on mouse chromosome 1 and the CD2/LFA3 region on mouse chromosome 3. J Exp Med 171:2115, 1990
12. Duplay P, Lancki D, Allison JP: Distribution and ontogeny of CD2 expression by murine T cells. J Immunol 142:2998, 1989
13. Owen MJ, Jenkinson EJ, Brown MH, Sewell WA, Krissansen GW, Crumpton MJ, Owen JJT: Murine CD2 gene expression during fetal thymus ontogeny. Eur J Immunol 18:187, 1988
14. -/- mice in the absence of TCR beta chain expression. Int Immunol 6:995, 1994
15. Tarakhovsky A, Kanner SB, Hombach J, Ledbetter JA, Muller W, Killeen N, Rajewsky K: A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 269:535, 1995
16. Denning SM, Tuck DT, Vollger LW, Springer TA, Singer KH, Haynes BF: Monoclonal antibodies to CD2 and lymphocyte function-associated antigen 3 inhibit human thymic epithelial cell-dependent mature thymocyte activation. J Immunol 139:2573, 1987
17. Vollger LW, Tuck DT, Springer TA, Haynes BF, Singer KH: Thymocyte binding to human epithelial cells is inhibited by monoclonal antibodies to CD2 and LFA-3 antigens. J Immunol 138:358, 1987
18. Smith ME, Thomas JA: Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule-1 in normal tissue. J Clin Pathol 43:893, 1990
19. Bell GM, Bolen J, Imboden JB: Association of Src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells. Mol Cell Biol 12:5548, 1992
20. Bell GM, Fargnoli J, Bolen JB, Kish L, Imboden JB: The SH3 domain of p561ck binds to proline-rich sequences in the cytoplasmic domain of CD2. J Exp Med 183:169, 1996
21. Beyers AD, Spruyt LL, Williams AF: Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5. Proc Natl Acad Sci USA 89:2945, 1992
22. Carmo AM, Mason DW, Beyers AD: Physical association of the cytoplasmic domain of CD2 with the tyrosine kinase p56lck and p59fyn. Eur J Immunol 23:2196, 1993
23. Gassman M, Amrein KE, Flint NA, Schraven B, Burn P: Identification of a signaling complex involving CD2, zeta chain and p59fyn in T lymphocytes. Eur J Immunol 24:139, 1994
24. Seed B, Aruffo A: Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci USA 84:3365, 1987
25. Sewell WA, Brown MH, Dunne J, Owen MJ, Crumpton MJ: Molecular cloning of the human T-lymphocyte surface CD2 (T11) antigen. Proc Natl Acad Sci USA 83:8718, 1986
26. Brown MH, Cantrell DA, Brattsand G, Crumpton MJ, Gullberg M: The CD2 antigen associates with the T-cell antigen complex on the surface of human T lymphocytes. Nature 339:551, 1989
27. Pawelec G, Schaudt K, Rehbein A, Olive D, Buhring H-J: Human T cell clones with GAMMAdelta and alphabeta receptors are differentially stimulated by monoclonal antibodies to CD2. Cell Immunol 129:385, 1990
28. Wesselborg S, Janssen O, Pechhold K, Kabelitz D: Selective activation of gammadelta+ T cell clones by single anti-CD2 antibodies. J Exp Med 173:297, 1991
29. Meuer SC, Hussey RE, Fabbi M, Foox M, Acuto O, Fitzgerald KA, Hodgon JC, Protntis JP, Schlossman SF, Reinherz EL: An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 36:897, 1984
30. Clark SJ, Law DA, Patterson DJ, Puklavec M, Williams AF: Activation of rat T lymphocyte by anti-CD2 monoclonal antibodies. J Exp Med 167:1861, 1988
31. Guckel G, Berek C, Lutz M, Altevogt P, Schirrmacher V, Kyewski BA: Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J Exp Med 174:957, 1991
32. Qin L, Chavin KD, Lin J, Yagita H, Bromberg JS: Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival. J Exp Med 179:341, 1994
33. Miller GT, Hochman PS, Meier W, Tizard R, Bixler SA, Rosa MD, Wallner BP: Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses. J Exp Med 178:211, 1993
34. Gollob JA, Li J, Reinherz EL, Ritz J: CD2 regulates responsiveness of activated T cells to interleukin 12. J Exp Med 182:721, 1995
35. Wingren AG, Dahlenborg K, Bjorklund M, Hedlund G, Kalland T, Sjogren H-O, Ljungdahl A, Olsson T, Ekre H-P, Sansom D, Dohlsten M: Monocyte-regulated IFN-γ production in human T cells involves CD2 signaling. J Immunol 151:1328, 1993
36. Killeen N, Stuart SG, Littman DR: Development and function of T cells in mice with a disrupted CD2 gene. EMBO J 11:4329, 1992
37. Evans CF, Rail GF, Killeen N, Littman D, Oldstone MB: CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus. J Immunol 151:6259, 1993
38. Teh H-S, Kisielow P, Scott B, Kishi H, Uematsu Y, Bluthmann H, von Boehmer H: Thymic major histocompatibility antigens and the αβ T cell receptor determine the CD4/CD8 phenotype of T cells. Nature (London) 335:229, 1988
39. Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell JH, Loh DY: Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336:73, 1988
40. Tarakhovsky A, Muller W, Rajewsky K: Lymphocyte populations and immune responses in CD5-deficient mice. Eur J Immunol 24:1678, 1994
41. Koller B, Marrack P, Kappler JW, Smithies O: Normal development of mice deficient in β2-microglobulin, MHC class I proteins, and CD8+ T cells. Science 248:1227, 1990
42. Staerz UD, Rammensee HG, Benedetto JD, Bevan MJ: Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J Immunol 134:3994, 1985
43. Kranz DM, Sherman DH, Sitkovsky MV, Pasternack MS, Eisen HN: Immunoprecipitation of cell surface structures of cloned cytotoxic T lymphocytes by clone-specific antisera. Proc Natl Acad Sci USA 81:573, 1984
44. Teh H-S, Kishi H, Scott B, Borgulya P, von Boehmer H, Kisielow P: Early deletion and late positive selection of T cells expressing a male-specific receptor in T-cell receptor transgenic mice. Dev Immunol 1:1, 1990
45. Springer T, Galfrie G, Secher DS, Milstein C: Monoclonal xenogeneic antibodies to murine cell surface antigens: Identification of novel leukocyte differentiation antigens. Eur J Immunol 8:539, 1978
46. Karasuyama H, Melchers F: Establishment of cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, or 5 using modified cDNA expression vectors. Eur J Immunol 19:97, 1988
47. Andersson G, Ekre H-P, Alm G, Perlmann P: Monoclonal antibody two-site ELISA for human IFN-γ. J Immunol Methods 125:89, 1989
48. Chernowski HM, Schumacher JH, Brown KD, Mosmann TR: Two types of mouse helper T cell clone. III. Further differences in Iymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monoclonal bioassays, and monoclonal anitbodies. J Exp Med 166:1229, 1987
49. Kisielow P, Teh H-S, Bluthman H, von Boehmer H: Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature 335:730, 1988
50. Udaka K, Tsomides TJ, Eisen HN: A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein. Cell 69:989, 1992
51. Udaka K, Tsomides TJ, Walden P, Fukusen N, Eisen HN: A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone. Proc Natl Acad Sci USA 90:11272, 1993
52. b antigen is altered by mutations that involve peptide binding. Proc Natl Acad Sci USA 87:6186, 1990
53. Sykulev Y, Brunmark A, Jackson M, Cohen RJ, Peterson PA, Eisen HN: Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity 1:15, 1994
54. Lee NA, Loh DY, Lacy E: CD8 surface levels alter the fate of α/β T cell receptor-expressing thymocytes in transgenic mice. J Exp Med 175:1013, 1992
55. Robey EA, Ramsdell F, Kioussis D, Sha W, Loh D, Axel R, Fowlkes BJ: The level of CD8 expression can determine the outcome of thymic selection. Cell 69:1089, 1992
56. Dutz JP, Ong CJ, Marth JD, Teh H-S: Distinct differentiative stages of CD4+CD8+ thymocyte development defined by lack of coreceptor binding in positive selection. J Immunol 154:2588, 1995
57. Borgulya P, Kishi H, Muller U, Kirberg J, Gray C, von Boehmer H: Development of the CD4 and CD8 lineage of T cells: Instruction versus selection. EMBO J 10:913, 1991
58. Swat W, Dessing M, Baron A, Kisielow P, von Boehmer H: Phenotypic changes accompanying positive selection of CD4+ CD8+ thymocytes. Eur J Immunol 22:2367, 1992
59. Jameson SC, Hogquist KA, Bevan MJ: Positive selection of thymocytes. Annu Rev Immunol 13:93, 1995
60. Kisielow P, Bluthmann H, Staerz UD, Steinmetz M, von Boehmer H: Tolerance in T cell receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333:742, 1988
61. Russell JH, Manning DE, McCulley DE, Meleedy-Rey P: Antigen as a positive and negative regulator of proliferation in cytotoxic lymphocytes. A model for the differential regulation of proliferation and lytic activity. J Immunol 140:1796, 1988
62. Speiser DE, Kyburz D, Stubi U, Hengartner H, Zinkernagel RM: Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but for in vivo protection. J Immunol 149:972, 1992